Delivery Order SPE2DB22D3016-SPE2DB25FBGF2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of VYVGART 400 mg/20 mL vials on July 28, 2025, with a completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $34,113.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This contract, with an ultimate completion date of October 14, 2025, represents a competitive, non-set-aside award to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $42,641.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyvgart 400 mg/20 mL vials. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by June 24, 2025, with performance to be fulfilled at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This competitive, firm fixed-price delivery order carries a ceiling value of $8,528.34 and is due for completion by August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,585.02 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of June 18, 2025. The contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $25,585.02 delivery order to AmerisourceBergen Drug Corp for VYVGART (efgartigimod) 400 mg/20 ml vials on August 18, 2025, with a completion deadline of September 9, 2025. This firm fixed-price order represents a competitively awarded, non-set-aside contract for the supply of this specialty pharmaceutical product to support military and federal healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $8,528.34 to AmerisourceBergen Drug Corp for the supply of VYVGART 400 mg/20 mL vials on August 19, 2025. This firm fixed price, non-set-aside contract is scheduled for completion by September 10, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. VYVGART is a specialty pharmaceutical product used in the treatment of myasthenia gravis, reflecting the Defense Logistics...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGF2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 ml vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a diverse portfolio of pharmaceutical products and medical supplies to support Defense Health Agency and other government healthcare systems. This delivery order for VYVGART, a specialized pharmaceutical product, exemplifies the company's role in fulfilling federal military medical supply requirements through the DLA's Medical Supply Chain. The transaction reflects AmerisourceBergen's capability to meet federal procurement requirements through open competition and its position as a key supplier within the Department of Defense's pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 8/26/25 |